Brief: Orexo Wins Patent Litigation For Zubsolv® In The Us
Orexo AB ORX.ST :
* OREXO WINS PATENT LITIGATION FOR ZUBSOLV® IN THE US
* DISTRICT COURT FOUND THAT OREXO'S PATENTS ARE VALID AND
INFRINGED BY SUN
* WIN WILL ENABLE OREXO TO MAINTAIN ZUBSOLV® NET SALES AND
PROFIT
CONTRIBUTION
* OREXO - AS A RESULT OF DECISION, SUN IS PROHIBITED FROM
LAUNCHING ITS GENERIC ZUBSOLV TABLETS UNTIL SEPTEMBER 2032
Source text for Eikon: ID:nWkr7CDDby
Further company coverage: ORX.ST
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens